Additional Information
Percentage | 30%, 31.25% |
---|---|
Documentation Available: | DMF in CTD Format |
Quality Standard | USP43 |
Release Type | Delayed Release |
Forms of PFI | Pellets (for capsules) |
Target Formulations | Capsules |
Murli Krishna Pharma Private Ltd.
D-98, MIDC Ranjangaon,
Taluka – Shirur, Dist. Pune – 412209
Maharashtra. India.
No Events Scheduled Currently…
© 2016 - 2025 - Murli Krishna Pharma • All Rights Reserved | Website designed & maintained by Mediavault
Murli Krishna Pharma Private Ltd.
D-98, MIDC Ranjangaon,
Taluka – Shirur, Dist. Pune – 412209
Maharashtra. India.